all news

Tue, 29 Sep 2026 Markets Insider - Business Insider

Tectonic Therapeutic announces results from Phase 1a trial of TX2100

Thu, 24 Sep 2026 Yahoo! Finance

Primmune Therapeutics Announces Enrollment Milestone in Phase 2 INFLECTION–003 Study of Polvitolimod HCl in Neoadjuvant Melanoma

Mon, 14 Sep 2026 GlobeNewswire

Wellthy Acquires Cleo as Two Leaders Come Together to Create the Singular Platform for Family Care

Mon, 14 Sep 2026 PR Newswire

FDA Approves ISEMBYLD™ for People Living with SMA

Tue, 11 Aug 2026 Associated Press

Cohere Health Ranks 390 on the 2026 Inc. 5000 List of Fastest-Growing Private Companies, Marking Second Consecutive Year

Tue, 11 Aug 2026 Yahoo! Finance

FloQast Recognized by Inc. as One of America's Fastest Growing Private Companies for Fourth Consecutive Year

Tue, 4 Aug 2026 GlobeNewswire

Cirrus Therapeutics Strengthens Its Position as a Next-Generation Global Ocular Immunology Leader with Singapore Eye Research Institute (SERI) Collaboration and Additional Financing

Tue, 4 Aug 2026 Business Wire

Satellite Bio Announces FDA Clearance of IND Application for SB-101 for the Treatment of Urea Cycle Disorders (UCDs) Marking its Transition to a Clinical-Stage Biotechnology Company

Tue, 4 Aug 2026 Benzinga

CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement

Tue, 28 Jul 2026 Targeted Oncology

FDA Approves SimpleScreen Blood Test for CRC Screening

Mon, 20 Jul 2026 Yahoo! Finance

Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection

Tue, 14 Jul 2026 Yahoo! Finance

Hummingbird Bioscience Wins APAC Trailblazer Award at 2026 Nebius AI Discovery Awards

Thu, 9 Jul 2026 PR Newswire

Freenome Reports Top-Line Readout of Updated SimpleScreen™ CRC Colorectal Cancer Screening Blood Test Met All Primary and Secondary Endpoints

Tue, 30 Jun 2026 Yahoo! Finance

TRexBio Announces Pipeline Progress, Naming TRB-071 as a CD30 Agonist for Immune-Mediated Diseases and Advancement of Lilly-Partnered TRB-051

Wed, 10 Jun 2026 GlobeNewswire

Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients

Tue, 2 Jun 2026 Yahoo! Finance

Tavo Biotherapeutics Announces $17 Million Series A Financing to Advance Novel Therapies in Glaucoma and Retinal Disease

Thu, 21 May 2026 Business Wire

Arsenal Medical Receives FDA IDE Approval for the RADIANT Pivotal Trial of NeoCast™ in Chronic Subdural Hematoma

Mon, 18 May 2026 Yahoo! Finance

Triveni Bio Doses First Healthy Volunteers with Next-Generation Bispecific Antibody TRIV-573 Targeting Kallikreins 5 & 7 and Interleukin 13 in Phase 1 Clinical Trial

Wed, 13 May 2026 Business Wire

Dyno Therapeutics Announces Expanded Frontiers Network and Second Annual Genetic Agency Technology Conference (GATC)

Wed, 13 May 2026 Business Wire

Dyno Therapeutics Launches Two New AAV Capsids and AI Platform for Rare Disease Therapeutic Development at the 2026 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

Mon, 11 May 2026 Yahoo! Finance

OM1 Supports 650,000 Patient Real-World Regulatory Submission for FDA Approval of Hologic's Aptima HPV Assay

Fri, 8 May 2026 Podimetrics

Podimetrics Named “Best New Monitoring Technology Solution” in 2026 MedTech Breakthrough Awards Program

Thu, 7 May 2026 FierceBiotech

Roche shells out up to $1B for PathAI in move to boost artificial intelligence-powered diagnostics

Tue, 5 May 2026 BioSpace

QurAlis’ Phase 2 data bolster case for genetic approach to sporadic ALS

Mon, 4 May 2026 BioSpace

Satellite Bio Announces FDA Rare Pediatric Disease Designation for SB-101 for the Treatment of Urea Cycle Disorders (UCDs)

Sun, 3 May 2026 Associated Press

UCB to Acquire Candid Therapeutics, Building Upon Its Existing Immunology Pipeline With Novel T-cell Engagers

Fri, 1 May 2026 Business Wire

TRexBio Doses First Patient with Moderate-to-Severe Atopic Dermatitis in Phase 1b Clinical Trial of TRB-061, a TNFR2 Agonist

Fri, 24 Apr 2026 PR Newswire

Nomad Health Evolves from Staffing Agency to the AI Operating System for Healthcare Staffing Firms

Wed, 22 Apr 2026 Associated Press

Kallyope’s Phase 2b Study of Elismetrep, A Novel Approach for Treating Migraine, Presented at the American Academy of Neurology Annual Meeting

Fri, 10 Apr 2026 Medical Laboratory Observer

PathAI and MedStar Health enter into partnership to enhance digital pathology